We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
149 hedge funds and large institutions have $1.04B invested in Rocket Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 46 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
24% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 46
1.68% more ownership
Funds ownership: 98.13% → 99.81% (+1.7%)
5% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 21
1% more funds holding
Funds holding: 148 → 149 (+1)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
25% less capital invested
Capital invested by funds: $1.38B → $1.04B (-$343M)
74% less call options, than puts
Call options by funds: $65K | Put options by funds: $250K
Holders
149
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
2.35%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
57
Reduced
46
Closed
21
Calls
$65K
Puts
$250K
Net Calls
-$185K
Net Calls Change
-$257K
Top Buyers
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$21.9M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$18M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$10.9M |
| 4 |
N
Natixis
Paris,
France
|
-$4.92M |
| 5 |
PA
Perceptive Advisors
New York
|
-$4.86M |
